MannKind Corporation (Nasdaq: MNKD) today announced the termination of its license and collaboration agreement with sanofi-aventis U.S. LLC for the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE